磺脲类相关低血糖对心脏的影响
研究纳入30例磺脲类治疗的2型糖尿病患者,同步进行48小时连续血糖监测与动态心电图。9例(30%)发生低血糖,低血糖与QTc延长及QT动态性增高相关,室性与室上性早搏呈无显著差异的增多趋势。作者认为磺脲类相关低血糖可能有不良心血管后果。
要点
- 血糖控制良好的磺脲类治疗2型糖尿病患者中,30%发生低血糖,多夜间无症状。
- 低血糖与QT动态性增高相关(夜间0.193 vs 0.159,P=0.01),部分患者出现QTc延长。
- 室性与室上性早搏在低血糖期间呈无显著差异的增多趋势(中位率比1.58和1.33)。
核心结论
- 磺脲类相关低血糖在血糖控制良好的2型糖尿病中常见且常未被识别,部分个体出现QT动态性增高和QTc延长,作者认为可能有不良心血管后果。
研究设计与样本
- 30例磺脲类治疗的2型糖尿病患者接受48小时同步连续血糖监测和动态心电图。
- 分析低血糖期间(<3.5 mmol/L持续>20分钟)的QTc和QT动态性,并与血糖正常和高血糖合并期间比较。
- 低血糖期间心脏早搏率与血糖4-10 mmol/L时比较。
- 另有一个胰岛素治疗队列观察到相似的无显著差异结果。
主要发现
- 平均HbA1c为6.9%(52 mmol/mol)。
- 30例中9例(30%)检测到低血糖,发作通常为夜间(67%)和无症状(73%)。
- 9例低血糖患者中5例出现低血糖相关QTc延长,个体反应差异大。
- 发生低血糖者QT动态性高于未发生低血糖者(夜间0.193 vs 0.159,P=0.01),此发现在低血糖事件后持续存在。
- 低血糖期间室性和室上性早搏率呈无显著差异的增多趋势(中位率比1.58和1.33)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effect of sulfonylurea-related hypoglycemia on cardiac repolarization and ectopy in the setting of well-controlled type 2 diabetes. RESEARCH DESIGN AND METHODS: Thirty subjects with sulfonylurea-treated type 2 diabetes underwent 48 h of concurrent continuous glucose monitoring and ambulatory electrocardiography. Ventricular repolarization (QTc) and QT dynamicity were analyzed during periods of hypoglycemia (<3.5 mmol/L for >20 min) and compared with periods of euglycemia and hyperglycemia combined. Cardiac ectopy rates during hypoglycemia were compared with ectopy rates when blood glucose was 4-10 mmol/L. RESULTS: Mean HbA1c was 6.9% (52 mmol/mol). Hypoglycemia was detected in 9 of 30 subjects (30%); episodes were typically nocturnal (67%) and asymptomatic (73%). Hypoglycemia-associated QTc prolongation was seen in five of nine subjects with a large variation in individual response. Higher QT dynamicity, a poor prognostic factor in cardiac disease, was seen in subjects who experienced hypoglycemia compared with subjects who did not (0.193 vs. 0.159 for the nocturnal period; P = 0.01). This finding persisted after the hypoglycemic event. The rates of ventricular and supraventricular ectopy demonstrated a nonsignificant trend toward an increase during hypoglycemia (median rate ratio 1.58 and 1.33, respectively). Similar, nonsignificant results were observed in a separate insulin-treated cohort. CONCLUSIONS: Hypoglycemia, often unrecognized, is a frequent finding in well-controlled sulfonylurea-treated type 2 diabetes. It is associated with the novel finding of increased QT dynamicity and QTc prolongation in some individuals. Our findings suggest sulfonylurea-related hypoglycemia can have detrimental cardiovascular sequelae. Similar effects are also seen in the setting of insulin therapy.
引用
- Middleton TL, Wong J, Molyneaux L, et al. Cardiac Effects of Sulfonylurea-Related Hypoglycemia. Diabetes Care. 2017. PMID: 28223296. doi:10.2337/dc16-1972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。